Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Apr 9, 2020

Total Value: $482M (100.0% shares, 0.0% debt)

Holdings (43)

SRPT SAREPTA THERAPEUTICS INC 9.1%
Value $44.07M Shares 290,000 Share Price $151.95 * Est. Cost/Share $121.54 Unrealized @ Report Date 0.0%
XBI SPDR SERIES TRUST 9.1%
Value $43.85M Shares 500,000 Share Price $87.71 Est. Cost/Share — Unrealized @ Report Date —
QQQ INVESCO QQQ TR 7.7%
Value $37.35M Shares 200,000 Share Price $186.74 Est. Cost/Share — Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 7.3%
Value $35.37M Shares 375,000 Share Price $94.33 Est. Cost/Share $85.19 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 7.2%
Value $34.51M Shares 335,000 Share Price $103.00 Est. Cost/Share $71.66 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 5.4%
Value $25.91M Shares 225,000 Share Price $115.15 Est. Cost/Share $95.44 Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 4.5%
Value $21.89M Shares 850,000 Share Price $25.75 * Est. Cost/Share $16.12 Unrealized @ Report Date +24.3%
ACAD ACADIA PHARMACEUTICALS INC 4.2%
Value $20.05M Shares 750,000 Share Price $26.73 * Est. Cost/Share $23.61 Unrealized @ Report Date +8.2%
FOLD AMICUS THERAPEUTICS INC 3.8%
Value $18.1M Shares 1,450,000 Share Price $12.48 Est. Cost/Share $11.72 Unrealized @ Report Date +8.3%
— GLOBAL BLOOD THERAPEUTICS IN 3.3%
Value $15.78M Shares 300,000 Share Price $52.60 Est. Cost/Share $49.14 Unrealized @ Report Date —
ARGX ARGENX SE 2.9%
Value $14.16M Shares 100,000 Share Price $141.58 Est. Cost/Share $141.58 Unrealized @ Report Date —
— IMMUNOMEDICS INC 2.3%
Value $11.1M Shares 800,000 Share Price $13.87 Est. Cost/Share $8.35 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 2.3%
Value $10.88M Shares 150,000 Share Price $72.56 * Est. Cost/Share $87.26 Unrealized @ Report Date -12.1%
BCRX BIOCRYST PHARMACEUTICALS 2.0%
Value $9.475M Shares 2,500,000 Share Price $3.79 * Est. Cost/Share $6.16 Unrealized @ Report Date -2.3%
— RA PHARMACEUTICALS INC 1.9%
Value $9.021M Shares 300,000 Share Price $30.07 Est. Cost/Share $22.40 Unrealized @ Report Date —
FXF INVESCO CURNCYSHS SWISS FRAN 1.8%
Value $8.751M Shares 92,200 Share Price $94.91 Est. Cost/Share $94.55 Unrealized @ Report Date —
— IMMUNOMEDICS INC 1.7%
Value $8.322M Shares 600,000 Share Price $13.87 Est. Cost/Share $8.35 Unrealized @ Report Date —
— CYMABAY THERAPEUTICS INC 1.5%
Value $7.16M Shares 1,000,000 Share Price $7.16 Est. Cost/Share $11.75 Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 1.4%
Value $6.9M Shares 460,000 Share Price $15.00 * Est. Cost/Share $16.85 Unrealized @ Report Date +3.5%
KALV KALVISTA PHARMACEUTICALS INC 1.4%
Value $6.645M Shares 300,000 Share Price $22.15 * Est. Cost/Share $16.62 Unrealized @ Report Date +41.1%
VRAYQ VIEWRAY INC 1.4%
Value $6.608M Shares 750,000 Share Price $8.81 * Est. Cost/Share $6.99 Unrealized @ Report Date +16.2%
MIST MILESTONE PHARMACEUTICALS IN 1.4%
Value $6.516M Shares 240,000 Share Price $27.15 * Est. Cost/Share $20.62 Unrealized @ Report Date 0.0%
PFE PFIZER INC 1.3%
Value $6.498M Shares 150,000 Share Price $43.32 Est. Cost/Share — Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.3%
Value $6.225M Shares 500,000 Share Price $12.45 Est. Cost/Share $12.26 Unrealized @ Report Date —
— ZYMEWORKS INC 1.3%
Value $6.05M Shares 275,000 Share Price $22.00 Est. Cost/Share $22.00 Unrealized @ Report Date —
— EPIZYME INC 1.2%
Value $5.836M Shares 465,000 Share Price $12.55 Est. Cost/Share $12.39 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 1.1%
Value $5.493M Shares 30,000 Share Price $183.10 Est. Cost/Share $158.27 Unrealized @ Report Date —
— SPARK THERAPEUTICS INC 1.1%
Value $5.119M Shares 50,000 Share Price $102.38 Est. Cost/Share $102.38 Unrealized @ Report Date —
ARVN ARVINAS INC 1.0%
Value $4.948M Shares 225,000 Share Price $21.99 * Est. Cost/Share $17.47 Unrealized @ Report Date +20.3%
— BIOHAVEN PHARMACTL HLDG CO L 0.9%
Value $4.379M Shares 100,000 Share Price $43.79 Est. Cost/Share $43.79 Unrealized @ Report Date —
— KADMON HLDGS INC 0.9%
Value $4.326M Shares 2,100,000 Share Price $2.06 Est. Cost/Share $3.79 Unrealized @ Report Date —
CHRS COHERUS BIOSCIENCES INC 0.8%
Value $3.868M Shares 175,000 Share Price $22.10 * Est. Cost/Share $13.34 Unrealized @ Report Date +30.2%
— DICERNA PHARMACEUTICALS INC 0.8%
Value $3.701M Shares 235,000 Share Price $15.75 Est. Cost/Share $15.75 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 0.8%
Value $3.678M Shares 150,000 Share Price $24.52 * Est. Cost/Share $9.65 Unrealized @ Report Date +56.0%
— ORCHARD THERAPEUTICS PLC 0.7%
Value $3.399M Shares 242,950 Share Price $13.99 Est. Cost/Share $15.73 Unrealized @ Report Date —
— CHIASMA INC 0.6%
Value $2.988M Shares 400,000 Share Price $7.47 Est. Cost/Share $5.20 Unrealized @ Report Date —
QURE UNIQURE NV 0.6%
Value $2.735M Shares 35,000 Share Price $78.14 * Est. Cost/Share $63.72 Unrealized @ Report Date 0.0%
— HOMOLOGY MEDICINES INC 0.5%
Value $2.446M Shares 125,000 Share Price $19.57 Est. Cost/Share $19.57 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.5%
Value $2.422M Shares 200,000 Share Price $12.11 * Est. Cost/Share $8.83 Unrealized @ Report Date +25.3%
— ODONATE THERAPEUTICS INC 0.5%
Value $2.385M Shares 65,000 Share Price $36.69 Est. Cost/Share $36.69 Unrealized @ Report Date —
— ARQULE INC 0.5%
Value $2.202M Shares 200,000 Share Price $11.01 Est. Cost/Share $11.01 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 0.1%
Value $575K Shares 100,000 Share Price $5.75 Est. Cost/Share $9.20 Unrealized @ Report Date —
— ALLAKOS INC 0.1%
Value $455K Shares 10,500 Share Price $43.33 Est. Cost/Share $43.33 Unrealized @ Report Date —